Tuesday May 30, 2023
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Conference & Exhibition
    • |Cell & Gene Therapy Manufacturing & Commercialization US
    • |Well Characterized Biologics & Biological Assays
    • |Cell & Gene Therapy Manufacturing & Commercialization Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Biosimilars
    • Cell/Gene Therapies
    • Continuous Bioprocessing
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Fill/Finish
    • Formulation
    • Information Technology
    • MAb
    • Manufacturing Contract Services
    • Personalized Medicine
    • Process Monitoring and Controls
    • Single Use
    • Supply Chain
    • Vaccines
    • Validation
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

November 2006

Vaccines: Quality Control, Scale-Up, and Manufacture

by BPI Contributor
November 1, 2006

The Market Need for Reconstitution Systems

by BPI Contributor
November 1, 2006

The Expanding Role of Biologics in the Pharmaceutical Industry

by BPI Contributor
November 1, 2006

Design and Performance of Viral Clearance Studies

by BPI Contributor
November 1, 2006

Products, Services, and Literature

by BPI Contributor
November 1, 2006

Considerations for Aseptic Filling of Parenterals

by BPI Contributor
November 1, 2006

Building Process Control into Chromatographic Purification of Viruses, Part 1

by BPI Contributor
November 1, 2006

Chromatography Advisor #6

by BPI Contributor
November 1, 2006

An Experimental Approach to Optimization of Ultrafiltration

by BPI Contributor
November 1, 2006

BPI Reports

by BPI Contributor
November 1, 2006
  • 1
  • 2
  • >

  • BioProcess Insider

    Moderna lays out $322m for mRNA manufacturing plant in MA

  • BioProcess Insider

    Catalent limiting CAPEX as part of cost reduction plan

  • Sponsored Content

    Development of IEX Purification Process for Lentiviral Vectors

  • BioProcess Insider

    Bavarian Nordic: Boosting inhouse manufacturing drives vaccine ambition

  • BioProcess Insider

    WHO-backed mRNA tech transfer platform looks beyond COVID, says MPP

  • Sponsored Content

    Innovation of Novel Purification Strategies – A Case Study of a Clusterin Scavenger Resin


BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Development of IEX Purification Process for Lentiviral Vectors." Date: T… https://t.co/vgK15PE2rB 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/7jyYh7UsoM 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/zokTnEdk6F 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/lR7nAmnryf 2 weeks ago
Follow @bioprocessintl

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2023 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International Conference & Exhibition
    • Cell & Gene Therapy Manufacturing & Commercialization US
    • Well Characterized Biologics & Biological Assays
    • Cell & Gene Therapy Manufacturing & Commercialization Europe
  • BioProcess International Academy
  • Events